Medication Delivery via Nebulizers

Jet Nebulizers

The American Thoracic Society recommends bronchodilators such as salbutamol (2.5-5 mg) or terbutaline (5-10 mg) for acute exacerbations of asthma and COPD, with a delivery efficiency of 38-55% of the loaded medication dose 1, 2
The European Respiratory Society suggests anticholinergics like ipratropium bromide (250-500 μg) for COPD exacerbations and severe asthma, often combined with beta-agonists for enhanced bronchodilation in severe cases 2, 3
The Infectious Diseases Society of America recommends antibiotics be delivered via standard flow rate compressor (6 L/min) with breath-enhanced open vent nebulizer, with thorough cleaning after each use to prevent bacterial growth 4
The American College of Chest Physicians states that nebulized corticosteroids have limited evidence in adults with asthma, but may be considered in steroid-dependent asthmatic patients to reduce oral corticosteroid doses 2
The American Academy of Pediatrics recommends antiviral agents like ribavirin (20 mg/ml solution) for high-risk infants with severe bronchiolitis, administered via small particle aerosol generator for 12-18 hours/day for 3-7 days 1, 5

The American Thoracic Society advises against using ultrasonic nebulizers for suspensions or solutions that are viscous, heat-sensitive medications, or antibiotics, due to limited medication compatibility 4

The American College of Chest Physicians recommends device selection based on patient factors, such as using jet nebulizers for patients unable to perform deep inhalations and breath-holding necessary for metered-dose inhalers, with face masks being tight-fitting and patients breathing with an open mouth for optimal delivery 4
The European Respiratory Society suggests safety precautions, such as driving nebulizers with air rather than oxygen to prevent worsening hypercapnia in patients with carbon dioxide retention and acidosis, and using mouthpieces instead of masks for ipratropium bromide to prevent glaucoma 2, 6, 4
The Infectious Diseases Society of America recommends maintenance requirements, including disassembling, washing, and drying nebulizers used for bronchodilator therapy daily, and changing standard jet nebulizers, tubing, and mouthpieces used for antibiotics every three months 4

The British Thoracic Society recommends using oxygen as the driving gas only in acute severe asthma because these patients are hypoxic and require simultaneous treatment of both bronchospasm and hypoxemia 7, 8
The British Thoracic Society suggests using compressed air (not oxygen) for COPD exacerbations to prevent worsening carbon dioxide retention and acidosis 9, 10
If supplemental oxygen is needed during air-driven nebulisation, the American Thoracic Society recommends administering low-flow oxygen (4 L/min) via nasal cannulae simultaneously 7

For acute severe asthma, the American College of Chest Physicians recommends administering nebulised salbutamol 5 mg (or terbutaline 10 mg) driven by oxygen at 6-8 L/min, repeated every 20-30 minutes for the first hour, then 4-6 hourly; add ipratropium bromide 500 µg if poor initial response 7, 8
The European Respiratory Society recommends using salbutamol 5 mg (or 0.15 mg/kg) or terbutaline 10 mg (or 0.3 mg/kg) for acute severe asthma in children 11
For COPD exacerbations, the Global Initiative for Chronic Obstructive Lung Disease recommends using salbutamol 2.5-5 mg or terbutaline 5-10 mg or ipratropium bromide 500 µg, given 4-6 hourly for 24-48 hours or until clinical improvement 9, 10

The American Association for Respiratory Care recommends using masks for acutely ill patients (too breathless to hold mouthpiece) and babies and young children with poor coordination 7, 8
The British Thoracic Society suggests using mouthpieces for nebulised steroids (prevents facial deposition) and nebulised antibiotics (allows filter attachment) 7, 8

The American Thoracic Society warns that never using oxygen-driven nebulisers routinely in COPD due to carbon dioxide retention risk 7
The European Respiratory Society recommends measuring arterial blood gases in hospitalized patients; if CO₂ retention present, use air-driven nebulisation 9, 10
The American College of Chest Physicians recommends reassessing patients at 15, 30, 60, 120, 180, and 240 minutes and switching to hand-held inhaler 24-48 hours before hospital discharge 9, 10

The American Thoracic Society recommends using salbutamol 2.5-5 mg nebulized every 20 minutes for the first hour, then every 4-6 hours as needed, with oxygen as the driving gas for asthma and air for COPD, to simultaneously treat hypoxemia and bronchospasm, with a strength of evidence based on clinical trials 12
For severe cases or poor initial response, adding ipratropium bromide 500 µg to each nebulization is recommended, with a moderate strength of evidence from clinical studies 12
Peak expiratory flow should be measured before and after each treatment, and patients should be monitored for side effects such as tachycardia, tremor, and palpitations, with a high strength of evidence for the importance of monitoring 12

The American Academy of Pediatrics recommends weight-based dosing of 0.15 mg/kg (minimum 2.5 mg) every 20 minutes for three doses, then every 1-4 hours as needed, with a high strength of evidence from pediatric clinical trials 13
Salbutamol should be diluted in a minimum of 2-3 mL normal saline for adequate nebulization, with a moderate strength of evidence from pharmacological studies 13

For refractory severe asthma, continuous nebulization at 0.5 mg/kg/hour up to 10-15 mg/hour may be considered, with a low to moderate strength of evidence from case series and small clinical trials 13
Patients should be transitioned from nebulizer to metered-dose inhaler 24-48 hours before hospital discharge, once peak flow reaches >75% predicted with <25% diurnal variability, with a moderate strength of evidence from clinical trials 12